Inify Laboratories AB
AI-powered digital pathology lab providing fast cancer diagnostics for healthcare providers.
INIFY | ST
Overview
Corporate Details
- ISIN(s):
- SE0017486103
- LEI:
- 549300306YYJ3BX3VB98
- Country:
- Sweden
- Address:
- Scheeles väg 3, 171 65 Solna
- Website:
- https://www.inify.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Inify Laboratories AB provides cancer diagnostics through ultramodern laboratory services within pathology. The company operates a fully digital, standardized, and AI-supported workflow designed to optimize diagnostic quality and significantly reduce turnaround times for biopsy results. Initially specializing in prostate cancer diagnostics with its "Inify Prostate" decision support tool, the company has achieved a significant market share in Stockholm and is expanding into other areas, such as gastrointestinal diagnostics. Inify Laboratories serves healthcare providers and is undergoing international expansion, including into the UK market.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Inify Laboratories AB and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-29 11:57 |
Director's Dealing
Inify Laboratories - mandatory notification of trade
|
English | 189.8 KB | |
| 2025-08-27 08:00 |
Quarterly Report
Inify Laboratories: Stabil tillväxt i Sverige och första patientdiagnostiken le…
|
Swedish | 1.1 MB | |
| 2025-08-27 08:00 |
Quarterly Report
Inify Laboratories: Solid growth in Sweden and first patient diagnostics delive…
|
English | 1.1 MB | |
| 2025-08-27 08:00 |
Quarterly Report
Inify Laboratories: Sterk vekst i Sverige og første pasientdiagnostikk levert i…
|
English | 1.1 MB | |
| 2025-08-27 08:00 |
Earnings Release
Inify Laboratories: Stabil tillväxt i Sverige och första patientdiagnostiken le…
|
Swedish | 4.7 KB | |
| 2025-08-27 08:00 |
Earnings Release
Inify Laboratories: Solid growth in Sweden and first patient diagnostics delive…
|
English | 4.4 KB | |
| 2025-08-27 08:00 |
Earnings Release
Inify Laboratories: Sterk vekst i Sverige og første pasientdiagnostikk levert i…
|
Norwegian | 4.4 KB | |
| 2025-08-27 08:00 |
Quarterly Report
|
Swedish | 1.1 MB | |
| 2025-08-27 08:00 |
Quarterly Report
|
English | 1.1 MB | |
| 2025-05-21 08:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) – summary of Annual General Meeting
|
English | 180.9 KB | |
| 2025-05-21 08:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) – kommuniké från årsstämma
|
Swedish | 172.6 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - summary of Annual General Meeting
|
English | 180.9 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - kommuniké från årsstämma
|
Swedish | 172.6 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - summary of Annual General Meeting
|
English | 3.4 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - kommuniké från årsstämma
|
Swedish | 3.4 KB |
Automate Your Workflow. Get a real-time feed of all Inify Laboratories AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Inify Laboratories AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-29 | Olof Sandén | Other | Buy | 10,000 | 44,800.00 SEK |
| 2025-01-27 | Olof Sandén | Other | Buy | 6,840 | 28,659.60 SEK |
| 2023-07-05 | Magne Jordanger | Other | Buy | 650,000 | 6,500,000.00 EUR |
| 2022-08-19 | Magne Jordanger | Other | Buy | 336,950 | 2,560,820.00 EUR |
